$650 Million to Settle Blood Thinner Lawsuits
Thursday, May 29, 2014 - 07:10
in Mathematics & Economics
Boehringer Ingelheim said that it stood behind the safety of Pradaxa and believed the lawsuits lacked merit, but that settling the case allowed it to move on.